Comments to FDA: OTC Monograph Reform and User Fees Share page: Docket Number: FDA-2016-N-1092 While the monograph system has served our nation well, it has become cumbersome and outdated and needs to be modernized. Download Document Issues: OTC Medicines Monograph Reform User Fees Related Posts Comments Comments Regarding Provisions Pertaining to Preventing Access to U.S. Sensitive Personal Data and Government-Related Data Nov 28, 2024 Press Releases and Statements CHPA Responds to Nomination of Dr. Marty Makary for FDA Commissioner Nov 25, 2024 Polibrief Per-and Polyfluoroalkyl Substances (PFAS) Nov 20, 2024